Style | Citing Format |
---|---|
MLA | Jabbaralrikabi S, et al.. "Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis." Endocrinology# Diabetes and Metabolism, vol. 7, no. 3, 2024, pp. -. |
APA | Jabbaralrikabi S, Etemadi A, Morad M, Nowrouzi A, Panahi G, Mondeali M, Tooranighazvini M, Nasliesfahani E, Razi F, Bandarian F (2024). Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis. Endocrinology# Diabetes and Metabolism, 7(3), -. |
Chicago | Jabbaralrikabi S, Etemadi A, Morad M, Nowrouzi A, Panahi G, Mondeali M, Tooranighazvini M, Nasliesfahani E, Razi F, Bandarian F. "Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis." Endocrinology# Diabetes and Metabolism 7, no. 3 (2024): -. |
Harvard | Jabbaralrikabi S et al. (2024) 'Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis', Endocrinology# Diabetes and Metabolism, 7(3), pp. -. |
Vancouver | Jabbaralrikabi S, Etemadi A, Morad M, Nowrouzi A, Panahi G, Mondeali M, et al.. Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis. Endocrinology# Diabetes and Metabolism. 2024;7(3):-. |
BibTex | @article{ author = {Jabbaralrikabi S and Etemadi A and Morad M and Nowrouzi A and Panahi G and Mondeali M and Tooranighazvini M and Nasliesfahani E and Razi F and Bandarian F}, title = {Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis}, journal = {Endocrinology# Diabetes and Metabolism}, volume = {7}, number = {3}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Jabbaralrikabi S AU - Etemadi A AU - Morad M AU - Nowrouzi A AU - Panahi G AU - Mondeali M AU - Tooranighazvini M AU - Nasliesfahani E AU - Razi F AU - Bandarian F TI - Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis JO - Endocrinology# Diabetes and Metabolism VL - 7 IS - 3 SP - EP - PY - 2024 ER - |